trials, page-4

Stainless , he said they were 2/3 through the trials , that would have them finishing in December , although he said they were seeing strong evidence of efficacy at this early stage , so it is possible they could finish a little early . I have never heard of a cancer drug showing a strong reaction against a cancer at his early stage of a phase1 trial . They are probably only using ratios lower than it took to get a reaction in mice at this stage .
Good Luck
Skint